Genistein inhibits expression of vascular endothelial growth factor in HER-2/neu transfected human breast cancer MCF-7 cells

Chinese Journal of Cancer Research

Volumn 18, Issue 2, 2006, Pages 83-87

  Zhu, Jun Dong ^a   Yu, Xiao Ping ^a   Mi, Man Tian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Genistein; HER 2 neu; Vascular endothelial growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENISTEIN; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; XENOGRAFT;

EID: 33745907565     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-006-0083-0     Document Type: Article

References (20)

1. Zetter BR. Angiogenesis and metastasis[J]. Ann Rev Med 1998; 49: 407-24.
2. McNamara DA, Harmey JH, Walsh TN, et al. Significance of angiogenesis in cancer therapy[J]. Br J Surg 1998; 85: 1044-5.
3. Marme D. Tumor angiogenesis: the pivotal role of vascular endothelial growth factor[J]. World J Urol 1996; 14: 166-74.
4. Toikkanen S, Helin H, Isola J, et al. prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up[J]. J Clin Oncol 1992; 10: 1044-8.
5. Yen L, You XL, Al Moustafa AE, et al. Heregulin selectively upregulates vascular endotherlial growth factor secretion in cancer cells and stimulates angiogenesis[J]. Oncogene 2000; 19: 3460-9.
6. Epstein M, Ayala R, Tchekmedyian N, et al. HER-2/neu-overexpssing human breast cancer xenografts exhibit increased angiogenic potential mediated by vascular endothelial growth factor (VEGF)[J]. Breast Cancer Res Treat 2002; 76(S1): S143.
7. Izumi Y, Xu L, di Tomaso E, et al. Tumor biology: herceptin acts as an anti-angiogenic cocktail[J]. Nature 2002; 416: 279-80.
8. Zhu JD, Yu XP, Mi MT. Inhibitory effect of genistein on the angiogenesis in HER-2/neu-overexpressing breast cancer xenograft in nude mice[J]. Chin J Clin Rehab 2005; 9: 228-30.
9. Etoh T, Inoue H, Tanaka S, et al. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases[J]. Cancer Res 2001; 61: 2145-53.
10. Weidner N, Semple JP, Welch JR, et al. Tumorangiogenesis and metastasis-correlation in invasive breast carcinoma[J]. N Engl J Med 1991; 324: 1-8.
11. Kern FG, Lippman ME. The role of angiogenic growth factors in breast cancer progression[J]. Cancer Metastasis Rev 1996; 15: 213-9.
12. Margolin K. Inhibition of vascular endothelial growth factor in the treatment of solid tumors[J]. Curr Oncol Rep 2002; 4: 20-8.
13. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis[J]. Nature 1992; 359: 843-5.
14. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor[J]. Endocr Rev 1997; 18: 4-25.
15. Linderholm BK, Lindahl T, Holmberg L, et al. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer[J]. Cancer Res 2001; 61: 2256-60.
16. Jiang BH, Agani F, Passaniti A, et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression[J]. Cancer Res 1997; 57: 5328-35.
17. Liu W, Li J, Rothe RA. Heregulin regulation of Akt/protein kinase B in breast cancer Cells[J]. Biochem Biophys Res Communication 1999; 261: 897-903.
18. Konecny GE Meng YG, Untch M, et al. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients[J]. Clin Cancer Res 2004; 10: 1706-16.
19. Laughner E, Taghavi P, chiles K, et al. HER-2/neu signaling increases the rate of hypoxia-inducible factor 1 γ (HIF-1 α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression[J]. Mol Cell Biol 2001; 21: 3995-4004.
20. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases[J]. J Biol Chem 1987; 262: 5592-5.